{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:45:28Z","timestamp":1772786728086,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejvs.2019.08.007","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T17:11:27Z","timestamp":1572887487000},"page":"137-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["No Concluding Evidence on Optimal Activated Clotting Time for Non-cardiac Arterial Procedures"],"prefix":"10.1016","volume":"59","author":[{"given":"Orkun","family":"Doganer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arno M.","family":"Wiersema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Scholtes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan D.","family":"Blankensteijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kak K.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Jongkind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2019.08.007_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejvs.2012.06.008","article-title":"Prophylactic perioperative anti-thrombotics in open and endovascular abdominal aortic aneurysm (AAA) surgery: a systematic review","volume":"44","author":"Wiersema","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib2","first-page":"127","article-title":"Prophylactic intraoperative antithrombotics in open infrainguinal arterial bypass surgery: a systematic review","volume":"56","author":"Wiersema","year":"2015","journal-title":"J\u00a0Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.ejvs.2019.08.007_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1152\/ajplegacy.1918.47.3.328","article-title":"Two new factors in blood coagulation-heparin and pro-antithrombin","volume":"47","author":"Howell","year":"1918","journal-title":"Am J Physiol Cel Physiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib4","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1161\/01.CIR.103.24.2994","article-title":"Guide to anticoagulant therapy: heparin a statement for healthcare professionals from the American Heart Association","volume":"103","author":"Hirsh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2019.08.007_bib5","first-page":"1456298","article-title":"The use of heparin during endovascular peripheral arterial interventions: a synopsis","volume":"2016","author":"Wiersema","year":"2016","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.ejvs.2019.08.007_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0950-821X(05)80459-1","article-title":"Heparin and protamine use in peripheral vascular surgery: a comparison between surgeons of the society for vascular surgery and the European society for vascular surgery","volume":"8","author":"Wakefield","year":"1994","journal-title":"Eur J Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib7","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00270-013-0558-6","article-title":"Periprocedural prophylactic antithrombotic strategies in interventional radiology: current practice in The Netherlands and comparison with the United Kingdom","volume":"36","author":"Wiersema","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib8","first-page":"119","article-title":"Perioperative prophylactic antithrombotic strategies in vascular surgery: current practice in The Netherlands","volume":"56","author":"Wiersema","year":"2015","journal-title":"J\u00a0Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.ejvs.2019.08.007_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejvs.2018.09.020","article-title":"Editor's choice - European society for vascular surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms","volume":"57","author":"Wanhainen","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jama.1966.03100180108036","article-title":"Activated coagulation time of whole blood","volume":"196","author":"Hattersley","year":"1966","journal-title":"JAMA"},{"key":"10.1016\/j.ejvs.2019.08.007_bib11","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/00000542-199910000-00031","article-title":"Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques","volume":"91","author":"Despotis","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejvs.2019.08.007_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/108925320500900105","article-title":"Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function","volume":"9","author":"Shore-Lesserson","year":"2005","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.ejvs.2019.08.007_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bpa.2015.03.005","article-title":"Anticoagulation management associated with extracorporeal circulation","volume":"29","author":"Sniecinski","year":"2015","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib14","first-page":"797","article-title":"Heparin monitoring during coronary intervention: activated clotting time versus activated partial thromboplastin time","volume":"9","author":"Nath","year":"1993","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-5223(19)41500-6","article-title":"Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage","volume":"69","author":"Bull","year":"1975","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.103.7.961","article-title":"Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials","volume":"103","author":"Chew","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2019.08.007_bib17","first-page":"1291","article-title":"Protamine--antagonist to heparin","volume":"108","author":"Jaques","year":"1973","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ejvs.2019.08.007_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1160\/TH16-02-0117","article-title":"Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial","volume":"116","author":"Meesters","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejvs.2019.08.007_bib19","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2019.08.007_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0002-9610(79)90318-0","article-title":"Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgery","volume":"138","author":"Mabry","year":"1979","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1051-0443(91)72486-X","article-title":"Assessment of heparin anticoagulation during peripheral angioplasty","volume":"2","author":"Mulry","year":"1991","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1213\/00000539-199304000-00004","article-title":"The effect of epidural\/general and cervical plexus block anesthesia on activated clotting time in patients undergoing vascular surgery","volume":"76","author":"Gold","year":"1993","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1445-2197.1994.tb02056.x","article-title":"Peri-operative anticoagulant effects of heparinization for carotid endarterectomy","volume":"64","author":"Coyne","year":"1994","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/1053-0770(94)90162-7","article-title":"Use of the activated coagulation time and heparin dose-response curve for the determination of protamine dosage in vascular surgery","volume":"8","author":"Szalados","year":"1994","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.ejvs.2019.08.007_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0741-5214(95)70137-0","article-title":"Protamine use during peripheral vascular surgery: a prospective randomized trial","volume":"22","author":"Dorman","year":"1995","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1078-5884(97)80082-2","article-title":"Should heparin be reversed after carotid endarterectomy? A randomised prospective trial","volume":"13","author":"Fearn","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00006123-199909000-00003","article-title":"Safety and efficacy of fixed-dose heparin in carotid endarterectomy","volume":"45","author":"Poisik","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejvs.2019.08.007_bib29","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1161\/hs1001.096003","article-title":"Initial experience of platelet glycoprotein IIb\/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy","volume":"32","author":"Kapadia","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2019.08.007_bib30","first-page":"87","article-title":"Role of activated clotting times in carotid stenting with filter protection","volume":"16","author":"Castellan","year":"2003","journal-title":"J\u00a0Neuroradiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib31","first-page":"242","article-title":"In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant","volume":"15","author":"Shammas","year":"2003","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.surneu.2005.04.016","article-title":"Monitoring of activated coagulation time in carotid endarterectomy","volume":"64","author":"de Sousa","year":"2005","journal-title":"Surg Neurol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib33","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.amjcard.2005.12.062","article-title":"Evaluating the optimal activated clotting time during carotid artery stenting","volume":"97","author":"Saw","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib34","first-page":"6","article-title":"Eptifibatide in peripheral vascular interventions: results of the integrilin reduces inflammation in peripheral vascular interventions (INFLAME) trial","volume":"18","author":"Shammas","year":"2006","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jcin.2009.06.015","article-title":"Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in percutaneous peripheral intervention: a single-center experience","volume":"2","author":"Sheikh","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2019.08.007_bib36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1540-8183.2011.00642.x","article-title":"Low-dose protamine to facilitate earlier sheath removal from the femoral artery after peripheral endovascular intervention","volume":"24","author":"Hanna","year":"2011","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.avsg.2013.04.011","article-title":"Predictors of cervical bleeding after carotid endarterectomy","volume":"28","author":"Morales Gisbert","year":"2014","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCINTERVENTIONS.110.957381","article-title":"Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions: insight from a large, regional, multicenter registry","volume":"3","author":"Kasapis","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2019.08.007_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.avsg.2017.11.060","article-title":"Anticoagulation obtained below the arterial clamp using a single fixed bolus of heparin in vascular surgery: a pilot study","volume":"50","author":"Roy","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib40","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejvs.2017.07.006","article-title":"Individual differences in heparin sensitivity and their effect on heparin anticoagulation during arterial vascular surgery","volume":"54","author":"Veerhoek","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib41","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jvs.2017.11.079","article-title":"Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure","volume":"68","author":"Dieplinger","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib42","first-page":"61","article-title":"National institutes of health stroke scale (NIHSS)","volume":"60","author":"Kwah","year":"2014","journal-title":"J\u00a0Physiother"},{"key":"10.1016\/j.ejvs.2019.08.007_bib43","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The Thrombolysis in myocardial infarction (TIMI) trial. Phase I findings","volume":"312","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2019.08.007_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/archsurg.1940.04240010147010","article-title":"Heparin in surgical treatment of blood vessels","volume":"40","author":"Murray","year":"1940","journal-title":"Arc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib45","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1213\/ANE.0b013e31827e4e62","article-title":"Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass","volume":"116","author":"Finley","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib46","first-page":"81","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"26","author":"Norgren","year":"2007","journal-title":"Int Angiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2017.10.044","article-title":"The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm","volume":"67","author":"Chaikof","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib48","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jtcvs.2012.05.065","article-title":"Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: a randomized controlled trial","volume":"144","author":"Arsenault","year":"2012","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejvs.2019.08.007_bib49","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0735-1097(94)90636-X","article-title":"Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty","volume":"23","author":"Avendano","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2019.08.007_bib50","first-page":"330","article-title":"Reproducibility and variability of activated clotting time measurements in the cardiac catheterization laboratory","volume":"65","author":"Doherty","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2019.08.007_bib51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1160\/TH08-08-0528","article-title":"Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation","volume":"101","author":"Chia","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejvs.2019.08.007_bib52","first-page":"873","article-title":"Comparison of activated clotting times measured using the Hemochron Jr. Signature and Medtronic ACT Plus during cardiopulmonary bypass with acute normovolemic haemodilution","volume":"46","author":"Lee","year":"2018","journal-title":"J\u00a0Int Med Res"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588419314443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588419314443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:51:43Z","timestamp":1761047503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588419314443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1078588419314443"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2019.08.007","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No Concluding Evidence on Optimal Activated Clotting Time for Non-cardiac Arterial Procedures","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2019.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society for Vascular Surgery. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}